Bain Capital Life Sciences Opportunities IV, L.P. 13D and 13G filings for Olema Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-13 4:24 pm Sale | 2025-01-08 | 13G | Olema Pharmaceuticals, Inc. OLMA | Bain Capital Life Sciences Opportunities IV, L.P. | 7,095,780 9.990% | -374,434 (-5.01%) | Filing |
| 2024-12-11 4:30 pm Purchase | 2024-12-04 | 13G | Olema Pharmaceuticals, Inc. OLMA | Bain Capital Life Sciences Opportunities IV, L.P. | 7,470,214 9.990% | 7,470,214 (New Position) | Filing |